VACCINE AND NON-PHARMACOLOGICAL MEASURES IN SEASONAL INFLUENZA PREVENTION: CURRENT EVIDENCE ON EFFECTIVENESS
DOI:
https://doi.org/10.5281/zenodo.19947551Keywords:
seasonal influenza, influenza vaccine, vaccine effectiveness, non-pharmacological measures, hand hygiene, masks, ventilation, preventionAbstract
Seasonal influenza remains a major cause of acute respiratory morbidity, excess hospitalization, and preventable mortality worldwide, especially among older adults, young children, pregnant women, people with chronic diseases, and healthcare workers. This article reviews current evidence on the effectiveness of vaccination and non-pharmacological measures in seasonal influenza prevention. The manuscript was prepared as a structured narrative review in IMRAD format using contemporary recommendations of the World Health Organization and the U.S. Centers for Disease Control and Prevention, together with systematic reviews, randomized trials, and recent vaccine effectiveness reports. The evidence shows that annual vaccination remains the most effective single preventive intervention and reduces medically attended influenza, hospitalization, and disease severity, although protection varies by age, circulating subtype, and antigenic match. Modern preventive strategy has moved toward more individualized vaccine selection for specific populations, including the use of enhanced formulations for older adults where available. Non-pharmacological measures, including hand hygiene, respiratory etiquette, staying home when ill, improvement of indoor air, surface hygiene, and the selective use of well-fitted masks, provide complementary benefit, particularly during periods of high transmission, in crowded settings, and in households or institutions with vulnerable persons. At the same time, evidence from randomized trials indicates that the effect of masks and hand hygiene alone may be modest when interventions are implemented late or adherence is poor. The most rational modern approach is therefore not to oppose vaccination to non-pharmacological measures, but to combine them in a layered prevention model. Such a model is especially important for high-risk groups, outbreak control, and seasons in which vaccine effectiveness is suboptimal.
Downloads
References
1.World Health Organization. (2022, May 13). Vaccines against influenza: WHO position paper – May 2022. Weekly Epidemiological Record, 97(19), 185–208. https://www.who.int/publications/i/item/who-wer9719
2.Centers for Disease Control and Prevention. (2025, August 28). ACIP recommendations summary: Prevention and control of seasonal influenza with vaccines—United States, 2025–26 influenza season. https://www.cdc.gov/flu/hcp/acip/index.html
3.Centers for Disease Control and Prevention. (2025). Interim estimates of 2024–2025 seasonal influenza vaccine effectiveness—Four vaccine effectiveness networks, United States, October 2024–February 2025. MMWR. https://www.cdc.gov/mmwr/volumes/74/wr/mm7406a2.htm
4.Centers for Disease Control and Prevention. (2025, September 26). Key facts about seasonal flu vaccine. https://www.cdc.gov/flu/vaccines/keyfacts.html
5.Centers for Disease Control and Prevention. (2024, September 11). People at increased risk for flu complications. https://www.cdc.gov/flu/highrisk/index.htm
6.Wong, J. Y., Lim, W. W., Cheung, J. K., Murphy, C., Shiu, E. Y. C., Xiao, J., Chen, D., Xie, Y., Li, M., Xin, H., Szeto, M., Choi, S., & Cowling, B. J. (2025). Non-pharmaceutical interventions to reduce influenza transmission in households: A systematic review and meta-analysis. International Journal of Infectious Diseases, 150, 107291. https://doi.org/10.1016/j.ijid.2024.107291
7.Jefferson, T., Dooley, L., Ferroni, E., Al-Ansary, L. A., van Driel, M. L., Bawazeer, G. A., Jones, M. A., Hoffmann, T. C., Clark, J., Beller, E. M., Glasziou, P. P., & Conly, J. M. (2023). Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews, 1(1), CD006207. https://doi.org/10.1002/14651858.CD006207.pub6
8.Cowling, B. J., Chan, K.-H., Fang, V. J., Cheng, C. K. Y., Fung, R. O. P., Wai, W., Sin, J., Seto, W. H., Yung, R., Chu, D. W. S., Chiu, B. C. H., Lee, P. W., Chiu, M. C., Lee, H. C., Uyeki, T. M., Houck, P. M., Malik Peiris, J. S., & Leung, G. M. (2009). Facemasks and hand hygiene to prevent influenza transmission in households: A cluster randomized trial. Annals of Internal Medicine, 151(7), 437–446. https://doi.org/10.7326/0003-4819-151-7-200910060-00142
9.Aiello, A. E., Perez, V., Coulborn, R. M., Davis, B. M., Uddin, M., & Monto, A. S. (2012). Facemasks, hand hygiene, and influenza among young adults: A randomized intervention trial. PLOS ONE, 7(1), e29744. https://doi.org/10.1371/journal.pone.0029744
10.Wong, V. W. Y., Cowling, B. J., & Aiello, A. E. (2014). Hand hygiene and risk of influenza virus infections in the community: A systematic review and meta-analysis. Epidemiology and Infection, 142(5), 922–932. https://doi.org/10.1017/S095026881400003X
11.U.S. Environmental Protection Agency. (2025, September 8). Ventilation and respiratory viruses. https://www.epa.gov/indoor-air-quality-iaq/ventilation-and-respiratory-viruses
12.Centers for Disease Control and Prevention. (2025, August 18). Preventing respiratory illnesses. https://www.cdc.gov/respiratory-viruses/prevention/index.html
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India